Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SYSEYE specializes in R&D and manufacturing of advanced ophthalmic medical devices such as fundus cameras and AI-powered vision screening systems. Their products are widely used in hospitals and clinics domestically in China as well as internationally. The RetiCam3100 was ranked first among domestic fundus cameras by the China Medical Equipment Association based on technical parameters, company conditions, and clinical research. The company holds over a hundred patents/software copyrights and has passed CE13485 certification. No clinical trial results are relevant since this is a device manufacturer rather than a therapeutic developer. They emphasize continuous innovation with independent R&D to meet diverse customer needs for digital grading diagnosis, artificial intelligence eye health diagnostics, etc.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen New Vision Technology Co., Ltd..